Abstract Genetic programming is known to affect the peak bone mass and bone loss after maturation. However, little is known about how polymorphic genes on chromosome X (Chr X) modulate bone loss after maturation. We previously reported a quantitative trait locus (QTL) on Chr X, designated Pbd3, which had a suggestive linkage to bone mass, in male SAMP2 and SAMP6 mice. In this study, we aimed to clarify the effects of Pbd3 on the skeletal phenotype. We generated a congenic strain, P2.P6-X, carrying a 45.6-cM SAMP6-derived Chr X interval on a SAMP2 genetic background. The effects of Pbd3 on the bone phenotype were determined by microcomputed tomography (lCT), whole-body dual-energy X-ray absorptiometry (DXA), serum bone turnover markers, and histomorphometric parameters. Both the bone area fraction (BA/TA) on lCT and whole-body DXA revealed reduced bone loss in P2.P6-X compared with that in SAMP2. The serum concentrations of bone turnover markers at 4 months of age were significantly lower in P2.P6-X than in SAMP2, but did not differ at 8 months of age. These results were observed in female mice, but not in male mice. In conclusion, a QTL within a segregated 45.6-cM interval on Chr X is sex-specifically related to the rate of bone loss after maturation.
Introduction
A steady loss of bone in both women and men after the age of peak bone mass is a risk factor for osteoporosis. Schematically, there are two types of bone loss. One occurs in the transient period of rapid bone loss in postmenopausal women, which is characterized by increased bone resorption. The other is involutional bone loss with aging, which occurs in women and men, and is characterized by slow continuous bone loss [1] . Many factors affect involutional bone loss, including the environment, genetics, longevity, dietary intake, and sex. Genetic studies have shown that 50-90% of the variation in bone mineral density (BMD) is genetically determined [2] [3] [4] . However, only a few studies have investigated bone remodeling and involutional bone loss [5] [6] [7] [8] [9] [10] [11] [12] [13] , with only very few of those studies involving chromosome X (Chr X).
Senescence-accelerated mice (SAM) are a group of mouse strains used as model systems for studies of senescence. The SAM strains are recombinant-like inbred strains that are believed to have developed from unexpected outbreeding between the same authentic ancestor, AKR/J, and a few unknown strains [14] . The bone mass of each SAM strain peaks at 4-5 months of age. SAMP6 has been described as a model of senile osteoporosis because it exhibits reduced areal BMD, reduced rates of trabecular bone formation, reduced marrow osteogenesis, increased periosteal and medullary widths, and reduced bone strength but no deficit in the mineral apposition rate after 4 months of age [15] [16] [17] [18] .
We have reported two significant loci on Chrs 11 and 13 (designated Pbd1 and Pbd2, respectively) and one suggestive locus on Chr X (designated Pbd3) involved in bone mass, using F2 intercrosses between SAMP2, which exhibits a higher bone mass, and SAMP6 strains [19] . Pbd1 affects bone geometry and Pbd2 affects bone formation before maturation [20, 21] . We have suggested that Pbd3 has an effect on bone mass in the opposite direction; i.e., the SAMP2 allele results in a lower bone mass [19] . In this study, we generated a congenic strain, P2.P6-X, and clarified the function of this quantitative trait locus (QTL) using several parameters.
Materials and methods

Mice
All mice (both males and females) were handled according to the Guidelines for Animal Experiments of Kyoto University. No more than five mice were housed per cage (160 9 280 9 105 mm 3 ) under conventional conditions, with a 12:12 h light:dark cycle and free access to tap water and a commercial diet (CE-2; CLEA, Tokyo, Japan). All the mice were weaned at 28-32 days of age. The mice were euthanized by cardiac puncture under ether anesthesia at 4 or 8 months of age. Their femora were harvested immediately and stored in 70% ethanol after the soft tissues had been removed. Mice without macroscopically detectable pathological changes at autopsy were evaluated.
Construction of congenic mice
To produce the congenic strain, SAMP6 and SAMP2 were used as the donor and recipient strains, respectively. The SAMP6-derived genetic interval of Chr X was transferred onto a SAMP2-derived background by seven successive backcrosses (N7), followed by an intercross to establish homozygous founders (N7F1), as described previously [22] . The selected interval was checked with two PCRbased microsatellite markers (DXMit97 and DXMit113) at each generation. The probability of carrying an unlinked contaminating donor locus after seven backcrosses (N7) is 0.0078 [23] . To check for the removal of unselected SAMP6 genomic elements, each progeny from generations N5 to N7 was also screened with another 63 microsatellite markers, distributed at 2-5 markers per chromosome. The resultant congenic strain, designated P2.P6-X, was subsequently maintained by sister-brother mating. Finally, we confirmed the congenic strain by checking the alleles of N7F10 progeny selected at random with the 65 markers throughout the whole genome.
Microsatellite genotyping
Genomic DNA was extracted from the liver or the tail of the animal according to the manufacturer's protocol (QIAamp Tissue Kit; Qiagen, Hilden, Germany). Microsatellite markers were amplified by PCR using specific primers (Research Genetics, Huntsville, AL, USA) and the products were loaded on 4% agarose or 8% polyacrylamide gels and visualized with ethidium bromide. Details of the standard PCR reaction conditions have been described previously [19] . The map positions of the microsatellite markers and genes were derived from the Ensemble genome browser (http://www.ensembl.org/index.html).
Bone mineral density (BMD) assessed with dual-energy X-ray absorptiometry (DXA)
The BMD of the entire skeleton was determined with DXA, using a QDR-2000 densitometer (Hologic, Inc., Waltham, MA, USA), which was calibrated weekly with a hydroxyapatite phantom of the human lumbar spine. The analysis was performed using the small animal scan setting in the commercial software, ver. 7.20B (Hologic, Inc.).
Food was withheld the night before the examination to eliminate the confounding effects of undigested rodent chow on BMD assessment. The mice were anesthetized with a transperitoneal infusion of 50 lg/g sodium pentobarbiturate (Dainippon Pharmaceutical Co. Ltd, Tokyo, Japan), followed immediately by BMD scanning.
The scans were performed with the mice in a prone position, with each limb spread on our custom device, as described previously [24, 25] . DXA scanning was conducted longitudinally for each mouse at 4 and 8 months of age (n = 9-10 for each strain and sex). The mice were scanned three times, and the average values were used for the analysis.
The global window was defined as the whole-body image minus the calvarium, mandible, and teeth. Scans were performed with a collimator of 1.270 mm diameter, 0.800 mm line spacing, 0.761 mm point resolution, and an acquisition time of 12 min. The values were expressed as BMD in mg/cm 2 . The mean coefficient of variation for BMD using DXA was 2.09% [24] .
Morphometrical analysis by microcomputed tomography (lCT) lCT measurements were made with a high-resolution lCT apparatus (SMX-100CT; Shimadzu, Kyoto, Japan; n = 18-30 for each age and sex per strain). The left femurs were mounted on a rotary stage and scanned through 360°i n their entirety in 1800 equiangular steps. The morphometric properties of the femora were determined as previously described [20] . A cross-section was scanned at a position 60% along the bone from the tip of the femoral head, and the femoral length (FeLen) was measured under radiographic guidance at the same time. This scan was converted into a binary image at a fixed threshold. The bone area fraction (BA/TA, %), total area (TA, mm 2 ), bone area (BA, mm 2 ), medullary area (MA, mm 2 ), cortical thickness (CtTh, mm), long axis length (LongAxL, mm), short axis length (ShortAxL, mm), oblateness (OBL: LongAxL/ShortAxL), periosteal circumference (PsCir, mm), and endocortical circumference (EcCir, mm) were calculated using the free software Image-J (NIH; http://rsb.info.nih.gov/ij/). The scans were performed with a voxel size of 0.0107 9 0.0107 9 0.05 mm 3 . The mean coefficient of variation for BA/TA (%) on lCT was 0.281%.
To measure the trabecular bone parameters, the metaphyseal regions were scanned 120 times at 10.96 lm intervals (voxel size was 10.96 lm in all three spatial directions). The most distal slice was defined as the plane at which the growth plate had just disappeared from the cross-sections. After the trabecular region was extracted, the bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), and trabecular spacing (Tb.Sp) were calculated using the commercial software package VGStudio Max 1.2 (Visual Science, Tokyo, Japan).
Biochemical markers of bone turnover
All mice (n = 10 per strain for each age and sex) were fasted from the night before the examination, and blood samples were collected at a fixed time the next morning. Serum osteocalcin levels were measured with the sandwich enzyme-linked immunosorbent assay (ELISA) kit specific for mouse osteocalcin (Biomedical Technologies, Inc., Stoughton, MA, USA) and were expressed as ng/mL of serum. To quantify the C-terminal telopeptide of type collagen (CTx) in serum, the RatLaps ELISA (Nordic Bioscience Diagnostics A/S, OsteoPark, Denmark) was used. The serum concentration of CTx was expressed as ng/mL of serum. The activity of serum tartrate-resistant acid phosphatase (TRACP) 5b was measured using the Bone TRAP Assay (Suomen Bioanalytiikka Oy, Oulu, Finland), according to the manufacturer's instructions. TRACP 5b activity was expressed as U/L.
All three markers were measured in duplicate aliquots of each serum sample and extract, and the average values were used for the analysis.
Histomorphometric analysis of in vivo bone formation All 4-and 8-month-old female mice (n = 10 at each age per strain) were given intraperitoneal injections of calcein (C 30 H 26 O 13 , FW 622.5; Sigma-Aldrich, St. Louis, MO, USA) at a dose of 20 mg/kg at three and 17 days before euthanasia. Transverse sections of the midshaft of the right femur (100 lm thick) were prepared as described previously [26] and examined with a confocal laser-scanning microscope (Fluoview ver. 2.0, Olympus America Inc., Center Valley, PA, USA). Dynamic measures of cortical bone formation were determined based on the calcein labels using Image-J. We determined the double-labeled bone surface (dLS/BS), mineral apposition rate (MAR), and bone formation rate (BFR/BS) based on histomorphometric standards. The endocortical (Ec) and periosteal (Ps) surfaces were analyzed separately in accordance with the ASBMR nomenclature [27] .
Data analysis
All statistical analyses were performed with SPSS ver. 10 software (SPSS Inc., Chicago, IL, USA). The data sets with no significantly different variances, except whole-body BMD, were analyzed by two-way analysis of variance (ANOVA), with strain and age as the betweensubject factors, to detect major genotype effects between the congenic and parental strains. To examine the effects on the whole-body BMD, two-way repeated-measures ANOVA was used, with strain as the between-subject factor and age as the within-subject factor, because whole-body BMD was measured longitudinally in identical sets of mice. If an interaction was significant, analysis of any simple effect at each level was then conducted using the method of Winer et al. [28] . The analyses were conducted separately for the male and female mice. Differences were considered statistically significant when P \ 0.05.
Results
Construction of the congenic strain, P2.P6-X
We checked the polymorphisms on Chr X with 241 microsatellite markers, covering the region from 0.2 to 73.0 cM from the centromere. Only 18 markers were polymorphic between SAMP2 and SAMP6. These markers were DXMit56, DXMit63, DXMit90, DXMit96, DXMit97, DXMit101, DXMit106, DXMit110, DXMit113, DXMit120, DXMit126,DXMit149, DXMit163, DXMit165, DXMit177, DXMit187, DXMit194, and DXMit212.
No contamination with unselected SAMP6 genomic elements was found in either the N7F3 or N7F10 generations, examined with all 63 markers throughout the whole genome, except for the interval described below. No double recombination was found within the interval in any progeny animal. The 45.6 cM SAMP6-derived genetic interval (DXmit187-DXmit149), which was carried by P2.P6-X in a SAMP2 background, is shown in Fig. 1 . Figure 2 shows the age-related changes in whole-body BMD, measured longitudinally in identical sets of mice. In females, the mean values at 4 and 8 months of age were 47.68 ± 1.10 and 44.18 ± 1.07, respectively, in SAMP2, and 48.67 ± 0.72 and 47.37 ± 0.74, respectively, in P2.P6-X. There was a significant strain 9 age interaction effect (P \ 0.05) on BMD. There was a significant simple effect of age in SAMP2 (P \ 0.001) but not in P2.P6-X (P = 0.054). The simple effect of strain was significant at 8 months of age (P \ 0.01) but not at 4 months of age (P = 0.258; Fig. 2 ). In males, the mean values at 4 and 8 months of age were 47.40 ± 0.77 and 45.06 ± 0.50, respectively, in SAMP2, and 48.56 ± 0.86 and 45.87 ± 0.61, respectively, in P2.P6-X. There was no significant strain 9 age interaction effect (P = 0.785). There was a significant main effect of age (P \ 0.001), but there was not a significant main effect of strain (P = 0.211, Fig. 2 ). There was no significant difference between the strains at either 4 or 8 months of age.
BMD
In females, P2.P6-X showed a smaller age-dependent reduction in BMD than that observed in the background strain, SAMP2. Based on the BMD at 4 months of age, the mean rates of age-dependent BMD reduction at 8 months in SAMP2 and P2.P6-X were 7.34 and 2.67%, respectively, in females, and 4.94% and 5.54, respectively, in males.
Morphometric analysis of femora using lCT
Cortical bone
To clarify the effects of the QTL on bone properties in detail, a morphometric analysis of the femur was performed using lCT. Cross-sectional images of the femoral midshaft are shown in Fig. 3a .
In females, there were no differences in TA or PsCir between SAMP2 and P2.P6-X at 4 or 8 months of age, as shown in Table 1 . However, there were significant strain 9 age interaction effects on BA/TA, MA, CtTh, EcCir, and FeLen. At 8 months of age, BA and CtTh showed significantly greater values in P2.P6-X than in Fig. 1 Detailed Chr X map of the P2.P6-X congenic strain. The SAMP6-derived 45.6 cM interval is shown, with the unselected flanking interval (oblique-lined box) that was included in the selected interval (black box). Bold letters indicate those markers identified as homozygous for the SAMP6 alleles, including the two selected markers (underlined) Fig. 2 Age-related changes in BMD. Bone loss, reflected by the reduction in BMD, was slower in P2.P6-X than in SAMP2. Two-way repeated ANOVA showed a significant age 9 strain interaction effect in females but not in males. The simple effect of strain was significant at 8 months in females. The data shown are mean ± SE SAMP2 (P = 0.042 and P \ 0.001, respectively). MA and EcCir were significantly greater in SAMP2 than in P2.P6-X, but FeLen did not differ between the strains. There was a significant simple effect of strain on BA/TA at 8 months of age (P \ 0.001) but not at 4 months of age (P = 0.893). BA/TA was significantly greater in P2.P6-X at 8 months of age than in SAMP2. The mean values for BA/TA at 4 and 8 months of age were 64.9 ± 2.7 and 56.9 ± 3.3, respectively, in SAMP2, and 64.8 ± 2.4 and 61.4 ± 3.2, respectively, in P2.P6-X (Table 1 ). In males, there were no significant strain 9 age interaction effects or significant main effects of strain on BA/TA, TA, BA, MA, CtTh, PsCir, EcCir, or FeLen. There was a significant main effect of age on BA/TA in both SAMP2 and P2.P6-X (P \ 0.001, Table 1 ).
The mean reduction ratios (=[BA/TA 4-months -BA/ TA 8-months ]/BA/TA 4-months ) in SAMP2 and P2.P6-X were 12.3 and 5.25%, respectively, in females, and 10.7 and 11.8%, respectively, in males. The bone loss after maturation, as reflected in the reduction in the bone area fraction, was slower in P2.P6-X than in SAMP2 in females but not in males.
The cross-sectional shape of the femoral midshaft in P2.P6-X and SAMP2 at 4 and 8 months of age was compressed in the anteroposterior direction. The shape became rounder and less elliptic with age. The ShortAxL at 8 months of age was significantly longer than that at 4 months of age in both strains and sexes (P \ 0.001). However, OBL was more elliptical in P2.P6-X than in SAMP2 in both sexes at 8 months of age (female P = 0.039, male P = 0.001).
Trabecular bone
Three-dimensionally (3D) reconstructed images of the femoral metaphyses are shown in Fig. 3b . As shown in Table 2 , there were significant main effects of both strain and age on BV/TV in female mice, with no significant strain 9 age interaction effect. There were significant simple effects of strain on Tb.N (P \ 0.001) and Tb.Sp (P \ 0.001) at 8 months of age. Tb.N was larger in P2.P6-X than in SAMP2, whereas Tb.Sp was smaller in P2.P6-X than in SAMP2. There was no significant strain 9 age interaction, although age had a significant main effect on Tb.Th, whereas strain did not (Table 2) .
In male mice, there was no significant strain 9 age interaction effect and no difference between strains in BV/TV (P = 0.149), Tb.Th (P = 0.054), or Tb.Sp (P = 0.497). There was a significant strain 9 age interaction on Tb.N and a significant simple effect of age in SAMP2 (P \ 0.01), but not in P2.P6-X. There was no significant simple effect of strain on Tb.N.
Biochemical markers of bone turnover
The results for the bone turnover markers are shown in Table 3 . In females, two-way ANOVA with strain and age as the explanatory variables for osteocalcin, a bone formation marker, revealed a significant strain 9 age interaction effect. The simple effect of age on osteocalcin was significant in P2.P6-X (P \ 0.05) and in SAMP2 (P \ 0.001). The simple effect of strain was significant at 4 months (P \ 0.01) but not at 8 months (P = 0.940). The serum concentration of osteocalcin in P2.P6-X was significantly lower than that in SAMP2 at 4 months of age. In males, there was no significant strain 9 age Fig. 3 MicroCT images of SAMP2 and P2.P6-X at 4 and 8 months of age. a Cross-sectional images of the femoral midshaft (female). There was no significant difference between males and females or between the two strains at 4 months of age in BA/TA, PsCir, or EcCir. However, at 8 months of age, P2.P6-X had a larger cortical bone area and shorter endocortical circumference than those of SAMP2 in females. b Reconstructed 3D images of the femoral metaphysis (female). There was a significant strain difference on BV/ TV between SAMP2 and P2.P6-X. There were differences in the simple effects of strain on Tb.N and Tb.Sp between SAMP2 and P2.P6-X at 8 months of age interaction effect or significant main effect of strain, but there was a significant main effect of age. The mean reduction ratios (=[OC 4-months -OC 8-months ]/OC 4-months ) in SAMP2 and P2.P6-X were 61.3 and 41.3%, respectively, in females, and 43.7 and 46.4%, respectively, in males.
With regard to the bone resorption markers, there was a significant strain 9 age interaction effect on CTx in females (Table 3 ). There was a significant simple effect of age in P2.P6-X (P \ 0.05) and SAMP2 (P \ 0.001). There was a significant simple effect of strain at 4 months (P \ 0.01) but not at 8 months (P = 0.898). The serum concentration of CTx in P2.P6-X was significantly lower than that in SAMP2 at 4 months of age. In males, there was no significant strain 9 age interaction effect or significant main effect of strain, but there was a significant main effect of age (Table 3 ). The mean reduction ratios (=[CTx 4-months ) -CTx 8-months ]/CTx 4-months ) in SAMP2 and P2.P6-X were There was no significant main effect of strain on TRACP 5b activity in females, and no significant strain 9 age interaction, but there was a significant main effect of age (Table 3 ).
Histomorphometric analysis of in vivo bone formation
The results of the bone histomorphometric analysis are shown in Table 4 . In females, there were significant strain 9 age interaction effects on Ps.dLS/BS (P = 0.020), Ps.MAR (P = 0.020), and Ps.BFR/BS (P = 0.043). All three periosteal parameters (Ps.dLS/BS, Ps.MAR, and Ps.BFR/BS) in P2.P6-X were lower than those in SAMP2 at 4 months of age. The simple effect of strain on these markers was significant at 4 months of age (P \ 0.001, P \ 0.001, and P \ 0.001, respectively) but not at 8 months of age (P = 0.107, P = 0.743, and P = 0.502, respectively). The simple effect of age on Ps.dLS/BS and Ps.MAR was not significant in P2.P6-X (P = 0.629 and P = 0.176, respectively) but was significant in SAMP2 (P \ 0.01 and P \ 0.001, respectively). The simple effect of age on Ps.BFR/BS in P2.P6-X and SAMP2 was significant (P = 0.046 and P \ 0.001, respectively). There was no strain 9 age interaction on either Ec.MAR or Ec.BFR/BS, but there was a significant main effect of strain on Ec.MAR and Ec.BFR/BS (Table 4) .
In short, the periosteal morphometric parameters of bone formation in P2.P6-X were significantly lower than those in SAMP2, but the endosteal morphometric *,**,*** Compared with 4-month-old mice of the same strain: *P \ 0.05, **P \ 0.01, ***P \ 0.001 ,à P2.P6-X versus SAMP2 at the same age: P \ 0.01, 
ND not determined *,**,*** Compared with 4-month-old mice of the same strain: *P \ 0.05, **P \ 0.01, ***P \ 0.001 ,à P2.P6-X versus SAMP2 at the same age: P \ 0.01,
parameters in P2.P6-X were significantly higher than those in SAMP2.
Discussion
We previously conducted a QTL analysis of the peak bone masses of SAMP6 and SAMP2. We selected the combination of SAMP2 and SAMP6 because (1) SAMP2 exhibited the highest value for CTI of SAMP2, SAMR1, and SAMP6 [22] ; and (2) the lifespan of SAMP2 was closer to that of SAMP6 than to that of SAMR1 (median survivals of SAMP2, SAMP6, and SAMR1 were 304, 321, and 568 days, respectively [29] ). Shimizu et al. [19] identified three QTLs affecting bone mass between SAMP2 and SAMP6 and they have suggested that a locus on Chr X affects the peak bone mass in the opposite direction, as has been reported for other combinations of strains [30] [31] [32] [33] . In the present study, we developed a congenic mouse to clarify the effects of Pbd3 on the skeletal phenotype and demonstrated that the QTL within a segregated 45.6 cM interval of Chr X is related to the sex-specific rate of bone loss after maturation rather than to the peak bone mass. Two measurement modalities, BA/TA measured by lCT and BMD by DXA, revealed that the female congenic mouse, P2.P6-X, containing the 45.6 cM SAMP6 interval from Chr X in a SAMP2 background, loses less bone than does the female SAMP2 mouse. This difference in bone loss was seen in both femur (cortex and trabecular bone) and whole-body measurements and was confirmed with cross-sectional (lCT) and longitudinal (DXA) studies.
To analyze further the function of Pbd3 in the femoral bone, we examined the morphological bone properties using lCT and its dynamic parameters with bone histomorphometry. We detected significant differences in the OBL, cortical thickness, and endocortical circumference at 8 months of age. Pbd3 did not alter the femoral length (FeLen) but affected the cross-sectional shape of the femoral cortex after maturation and caused the cross-sectional shape of P2.P6-X to be more compressed than that of SAMP2. Mechanical testing showed no significant differences in the maximum failure load or stiffness between P2.P6-X and SAMP2 (data not shown), although it is well known that the mechanical properties of bone are affected by its shape and integral quality. Further analysis of bone quality is required to characterize the function of this QTL. Pbd3 affected the cortical thickness, and the femoral cortex of P2.P6-X was thicker than that of SAMP2 at 8 months of age. Several studies have proposed genes that affect cortical bone thickness during the growth period [34] [35] [36] , but there have been no reports of genes that affect cortical thickness after maturation. In this study, Ec.BFR/BS in P2.P6-X at 8 months of age was higher than that in SAMP2 (P = 0.026). The endocortical circumference (EcCir) of P2.P6-X was smaller than that of SAMP2 at 8 months of age, whereas the periosteal circumference did not differ between the strains, indicating that the SAMP6-type interval on Pbd3 has a positive association with cortical thickness and a negative association with endocortical circumference.
There was no difference between the strains or sexes in the concentrations of biochemical bone turnover markers in the growth period (data not shown). However, at maturity, female P2.P6-X mice exhibited lower concentrations of osteocalcin and CTx than those of SAMP2 at 4 months of age, and these levels decreased more slowly in P2.P6-X than in SAMP2. Garnero et al. [37, 38] , Ross and Knowlton [39] , and Dresner-Pollak et al. [40] have reported that higher concentrations of the biochemical markers of bone turnover indicate rapid bone loss in humans. The concentrations of bone turnover markers have been shown to relate strongly to bone loss after maturation in humans [41] [42] [43] . Despite the differences in osteocalcin and CTx levels, the serum concentrations of TRACP 5b in the P2.P6-X female mice were not significantly different from those in the female SAMP2 mice. Recent data have demonstrated the utility of TRACP 5b as a marker of osteoclast number and of CTx as a marker of osteoclast activity [44, 45] . Our results suggest that the SAMP6-derived interval depressed osteoclast activity at 4 months of age but did not alter osteoclast number. Osteocalcin is a small protein synthesized by mature osteoblasts, which is involved in the mineralization process, and is considered to be a marker of mature osteoblasts [46] . Circulating levels of osteocalcin reflect osteoblastic activity and the rate of bone formation [46, 47] . Our results imply that the SAMP6-derived interval depressed osteoblast activity at 4 months of age. However, because histomorphometric studies of osteocalcin-deficient mice showed an increase in the bone formation rate without an increase in osteoblast number [48] , the function of osteocalcin is not yet fully established. Bone loss after maturation is determined by aging and by genetic and environmental factors. Szumska et al. [49] reported QTLs that affect age-dependent BMD changes on Chrs 7 and X. These loci were identified in a linkage analysis comparing the ratios of 6-/4-month spinal BMD of SAMP6 and AKR/J. The phenotype of the congenic strain in the present study raises the possibility that the QTLs reported by Szumska et al. and us contain an identical candidate gene. However, the region that Szumska et al. suggested is beyond the range that we confirmed here. Christiansen [50] and Riis et al. [51] have argued that the velocity of bone loss after maturation is a risk factor for osteoporosis. However, there have been few reports of genes related to the rate of bone loss after maturation [52, 53] .
Several genes affect bone volume in a sex-specific manner [5, 10, 11, [54] [55] [56] [57] [58] [59] [60] [61] [62] . The androgen receptor (AR), biglycan (Bgn), regucalcin (Rgn), and phosphate-regulating gene with homologies to endopeptidases on the X chromosome (Phex) are on Chr X, and deletion of these genes has sex-specific effects on bone volume at maturation, with bone loss in males but not in females. Some of the genes on Chr X possibly affect bone biology differently in males and females, but this issue remains to be clarified. The results of the present study show that the candidate gene on Chr X contributes to bone maintenance in female mice after maturation and affects bone turnover. Bgn, AR, and Rgn are within the 45.6 cM SAMP6 interval. However, there are no differences in the DNA sequences of any of the exons of these genes between SAMP2 and P2.P6-X. Furthermore, their mRNA levels in the bone marrow, determined by reverse transcription PCR (RT-PCR), were similar in SAMP2 and P2.P6-X (data not shown). P2.P6-X does not exhibit hypophosphatemia, and its serum concentrations of calcium and phosphate were not significantly different from those of SAMP2 (data not shown), whereas the deletion of Phex results in hypophosphatemia [59] .
There are other potential candidate genes related to bone within the interval identified in this study [63] [64] [65] [66] [67] [68] [69] [70] [71] . However, the biological effects of most of these genes have not been clarified. The difference of haplotype (196Phe/532Ser) in interleukin-1 receptor-associated kinase 1 (Irak1) causes accelerated bone loss in postmenopausal women [66] . The SAMP2/P2.P6-X set could constitute a murine model for Irak1-related accelerated bone loss in humans if Irak1 proves to be the gene responsible in our interval. Methyl CpG binding protein 2 (Mecp2) is a transcription factor that was recently found to suppress the expression of the RANKL gene in mouse osteoblasts by contributing to the methylation of the RANKL gene promoter [72] . It has direct and indirect associations with the interferon gamma (IFN-c), estrogen receptor 1 (ESR1), and mitogen-activated protein kinase 3 (MAPK3) network in B cells [71] . Mecp2 is another possible candidate gene. Tsuboyama et al. [73] identified a strain-specific bone mass in SAMP2 and SAMP6 that was inherited as a polygenic characteristic and controlled by a relatively small number of genes. According to Wright's formula [74] , we inferred that the number of effective loci could be calculated to be 2.16 for CTI, and that there is no substantial epistasis. At 8 months of age, BA/TA, BA and CtTh showed the highest values in P2.P6-X, followed in decreasing order by SAMP2 and SAMP6, whereas TA, MA, PsCir, and EcCir were highest in SAMP6, followed by SAMP2 and P2.P6-X. These simple relationships suggest that SAMP6 Chr X has an additive effect in the opposite direction relative to the difference seen in the two parental strains, SAMP2 and SAMP6, and that the effect is explained by a single gene. However, OBL, a bone geometry parameter, had the highest value in SAMP6 and the lowest value in SAMP2, with P2.P6-X in between. This interstrain order was different from that seen in the parameters related to bone mass, such as BA/TA. These observations allow two interpretations: (1) that there may be other genes associated with bone geometry in our QTL, and (2) that there may be some genetic interactions on Chr X.
The congenic mice described in this study should provide a valuable resource in the search for genes involved in age-related bone loss. Currently, we are screening candidate genes by constructing subcongenic strains in which we are shortening the responsible interval. When the candidate gene is found, the next step will be to test the effect of this gene(s) on BMD variations in human populations using an association study. The identified gene could possibly be used in the future for the diagnosis of patients susceptible to osteoporosis. The identification of this gene could also lead to the future development of protein-or gene-based therapies for the treatment of bone diseases.
